Stable High-Concentration Monoclonal Antibody Formulations Enabled by an Amphiphilic Copolymer Excipient
J. H. Klich, C. M. Kasse, J. L. Mann, Y. Huang, A. I. d'Aquino, A. K. Grosskopf, J. Baillet, G. G. Fuller, E. Appel
This paper introduces an amphiphilic copolymer excipient that enhances the stability of high-concentration monoclonal antibody formulations without affecting pharmacokinetics or injectability.
bioRxiv · May 25, 2022Bioengineering